MIST · Milestone Pharmaceuticals Inc
United States · RS rating 16 · As of 2026-11-03
| Price | 0.76 USD |
|---|---|
| 1-day change | +5.3% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 50 / 18 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 6 / 32 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -5.0% |
| Sales growth Q/Q | -84.6% |
| Distance from 52-week high | +74.3% |
| Market cap (USD) | $220.0M |